Skip to main content

Table 1 Recipients’ characteristics

From: Improved long-term outcomes after heart transplantation utilizing donors with a traumatic mode of brain death

 

Non-traumatic brain death

(N = 85)

Traumatic brain death

(N = 105)

p-value

Gender (male, %)

75.4

83.5

0.217

Age (years)

47.4 ± 14.7

46.9 ± 13.9

0.331

Weight (kg)

72.0 ± 19.1

73.6 ± 15.1

0.717

Height (cm)

165.5 ± 27.1

170.9 ± 12.2

0.725

BMI

24.3 ± 4.4

24.8 ± 4.6

0.578

Ischemic etiology for HTx (%)

49.2

54.1

0.622

Hypertension (%)

20.0

27.6

0.221

Diabetes pre (%)

18.5

18.8

0.955

Dyslipidemia (%)

37.9

44.3

0.405

Past smoker (%)

38.2

35.6

0.826

CMV positive serology (%)

91.2

93.6

0.742

Status prior to transplantation (%)

  

0.228

 Status 1

70.8

60.0

 

 Status 2

29.2

40.0

 

Creatinine (mg/dL)

1.4 ± 1.1

1.2 ± 0.5

0.209

Bilirubin (mg/dL)

1.2 ± 0.8

1.1 ± 0.6

0.234

Systolic blood pressure (mmHg)

128.1 ± 22.1

129.1 ± 11.0

0.133

Diastolic blood pressure (mmHg)

73.2 ± 12.8

75.2 ± 11.6

0.257

Systolic PAP (mmHg)

54.1 ± 19.3

49.1 ± 20.1

0.405

Diastolic PAP (mmHg)

26.3 ± 10.8

24.4 ± 11.3

0.883

Mean PAP (mmHg)

36.7 ± 14.5

34.9 ± 13.9

0.994

PCWP

25.4 ± 11.3

25.1 ± 11.2

0.712

CO

3.5 ± 1.1

3.5 ± 1.1

0.671

PVR

3.1 ± 2.0

2.9 ± 2.5

0.871

ICD (%)

35.9

36.1

0.979

LVAD bridge to HTx

23.7

17.6

0.410

PRA > 30%

1.6

3.1

0.351

CMV mismatch

46.2

36.5

0.245

Blood type

  

0.713

 A

46.8

45.8

 

 AB

8.6

16.3

 

 B

13.3

22.4

 

 O

26.9

19.4

 
  1. BMI Body mass index, HTx Heart transplantation, CMV Cytomegalovirus, PAP Pulmonary artery pressure, PCWP Pulmonary capillary wedge pressure, CO Cardiac output, PVR Pulmonary vascular resistance, ICD Implantable cardioverter defibrillator, LVAD Left ventricular assist device, PRA Panel reactive antibody